TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19636035

Group type: EXPERIMENTAL
Intervention: Drugs flagged as potentially inappropriate by Beers criteria
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Drugs flagged as potentially inappropriate by Zhan criteria
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Drugs identified as problematic by the physician-pharmacist team
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Concordance between drugs-to-avoid criteria and expert assessments
Number of subjects: 256
Study: 17291938

Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study: 15113949

Group type: EXPERIMENTAL
Intervention: Tomato juice (330 mL/d for 2 weeks)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Carrot juice (330 mL/d for 2 weeks)
Number of subjects: 22
Study: 11339494

Group type: EXPERIMENTAL
Intervention: Rebound motion
Number of subjects: 27

Group type: COMPARATOR
Intervention: Concentric only motion
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Loading of 50‐70% 1RM
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Rebound technique
Number of subjects: 27
Study: 8994151

Group type: EXPERIMENTAL
Intervention: General explanation (unspecified medical condition)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Specific explanation (severe pneumonia)
Number of subjects: 186
Study: 8089635

Group type: EXPERIMENTAL
Intervention: Enalapril (5-10 mg/day)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control (alpha methyldopa 500 mg/day)
Number of subjects: 37
Study: 3316575

Group type: EXPERIMENTAL
Intervention: Cyclosporine alone (15 to 17 mg/kg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Cyclosporine plus prednisolone (0.3 mg/kg/d)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cyclosporine alone (8 to 10 mg/kg/d)
Number of subjects: 45
Study: 31858338

Group type: EXPERIMENTAL
Intervention: Oral treprostinil diolamine
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Nineteen biomarkers analyzed
Number of subjects: 124
Study: 30376872

Group type: COMPARATOR
Intervention: Standard of Care (SOC) including the Kenya Mentor Mother Program (KMMP)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: EMMA package of services (including targeted exit interview, visit reminders, and targeted follow‐up)
Number of subjects: 360
Study: 25967607

Group type: EXPERIMENTAL
Intervention: Hedan Tablet 4.38 g/day
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 26373406

Group type: EXPERIMENTAL
Intervention: Web-based, within-consultation, behavioural intervention
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study: 23329206

Group type: EXPERIMENTAL
Intervention: Sumatriptan infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 12
Study: 21343847

Group type: EXPERIMENTAL
Intervention: Behavioral Graded Activity (BGA)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Manual Therapy (MT)
Number of subjects: 146
Study: 19738591

Group type: EXPERIMENTAL
Intervention: Tympanoplasty (n=7)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mastoidoplasty with Stimul-oss (n=4)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Simultaneous tympano- and mastoidoplasty using Stimul-oss blocks (n=9)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Overall surgical treatment
Number of subjects: 20
Study: 17189470

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine treatment after acid-etching
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (customarily restored with etch-and-rinse adhesive/resin composite)
Number of subjects: 0
Study: 15041116

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Tadalafil with tadalafil dosing instructions
Number of subjects: 219

Group type: COMPARATOR
Intervention: Sildenafil 50 mg
Number of subjects: 219
Study: 11468015

Group type: EXPERIMENTAL
Intervention: diclofenac-K 12.5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ibuprofen 200 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: aspirin 500 mg
Number of subjects: 12
Study: 9693697

Group type: EXPERIMENTAL
Intervention: Adolescent Leisure Interest Profile (ALIP)
Number of subjects: 116
Study: 7573864

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (various concentrations)
Number of subjects: 7
Study: 2365538

Group type: EXPERIMENTAL
Intervention: SR nicardipine (40 mg twice a day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Chlorthalidone (25 mg once a day)
Number of subjects: 36
Study: 227072

Group type: EXPERIMENTAL
Intervention: Tiapride (300 mg/day, IM route)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Reference drug
Number of subjects: 30
Study: 31973115

Group type: EXPERIMENTAL
Intervention: Tele-SSE
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 118
Study: 31742587

Group type: EXPERIMENTAL
Intervention: Moderate-intensity endurance training program (3 sessions of 40 minutes per week for 8 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Nontraining group (maintained normal lifestyle)
Number of subjects: 32
Study: 28577685

Group type: EXPERIMENTAL
Intervention: Lisinopril (ACE inhibitor)
Number of subjects: 468

Group type: EXPERIMENTAL
Intervention: Carvedilol (BB)
Number of subjects: 468

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 468
Study: 25759969

Group type: EXPERIMENTAL
Intervention: TIPS
Number of subjects: 73

Group type: COMPARATOR
Intervention: EBL plus propranolol
Number of subjects: 73
Study: 26253735

Group type: EXPERIMENTAL
Intervention: OCT-guided Nobori biolimus-eluting stent implantation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Angiographic guidance only
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 23979365

Group type: EXPERIMENTAL
Intervention: IV ART-123 (0.06 mg/kg/d) for 6 days
Number of subjects: 750

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 750
Study: 21048093

Group type: EXPERIMENTAL
Intervention: Airtraq laryngoscope
Number of subjects: 108

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 108
Study: 18339140

Group type: EXPERIMENTAL
Intervention: Thymoglobulin (Thymo)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Alemtuzumab
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Daclizumab (Dac)
Number of subjects: 90
Study: 17154778

Group type: EXPERIMENTAL
Intervention: Implicit change detection task with corrected methodological biases
Number of subjects: 0

Group type: COMPARATOR
Intervention: Implicit change detection task
Number of subjects: 0
Study: 14584548

Group type: EXPERIMENTAL
Intervention: Directed forgetting (DF) by items in frontal patients with right side lesions
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Directed forgetting (DF) by lists in temporal patients with left side lesions
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Retrieval induced forgetting (RIF) in frontal patients
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Retrieval induced forgetting (RIF) in temporal patients
Number of subjects: 3

Group type: COMPARATOR
Intervention: Non-brain damaged controls
Number of subjects: 3
Study: 10948466

Group type: EXPERIMENTAL
Intervention: Epidural analgesia for labor pain relief
Number of subjects: 3142
Study: 9635652

Group type: EXPERIMENTAL
Intervention: Air insufflation technique (500 mL of air instilled into the stomach)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control technique (no air insufflation)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Air insufflation technique
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control technique
Number of subjects: 64
Study: 8171951

Group type: COMPARATOR
Intervention: Fentanyl (0.1 mg prior to surgery, 0.05 mg every 30 min during surgery)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Alfentanil (0.5 mg prior to surgery, 0.25 mg every 15 min during surgery)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fentanyl and Alfentanil
Number of subjects: 40
Study: 3335192

Group type: EXPERIMENTAL
Intervention: Kreon, three times six capsules daily
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Panzytrat 20.000, three times three capsules daily
Number of subjects: 9
Study: 31903807

Group type: EXPERIMENTAL
Intervention: FOLFIRI + cetuximab
Number of subjects: 0

Group type: COMPARATOR
Intervention: FOLFIRI + bevacizumab
Number of subjects: 0
Study: 29789878

Group type: EXPERIMENTAL
Intervention: Full-dose nut diet (75 g/day mixed nuts)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Full-dose muffin diet (three whole-wheat muffins, 188 g/day)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Half-dose nut diet (half portions of both nuts and muffins)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Full-dose nut diet
Number of subjects: 117
Study: 27389118

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided genicular nerve pulsed RF treatment
Number of subjects: 9
Study: 26023223

Group type: EXPERIMENTAL
Intervention: Walking at 1.25 m/s
Number of subjects: 17
Study: 23989798

Group type: EXPERIMENTAL
Intervention: Presence of pancreatic acinar cells
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Absence of pancreatic acinar cells
Number of subjects: 1071
Study: 21417811

Group type: EXPERIMENTAL
Intervention: Ozone therapy (major autohemotherapy, minor autohemotherapy, and rectal ozone insufflation)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Ozone therapy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional treatment (silymarin and/or multivitamins)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 52
Study: 18310363

Group type: EXPERIMENTAL
Intervention: Transobturator tape
Number of subjects: 170

Group type: COMPARATOR
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 170
Study: 16988569

Group type: EXPERIMENTAL
Intervention: Neuroticism (N)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: N-anx (anxiety subfacet)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: N-dep (depression subfacet)
Number of subjects: 75
Study: 14599834

Group type: EXPERIMENTAL
Intervention: Percutaneous release with steroid injection
Number of subjects: 115

Group type: COMPARATOR
Intervention: Steroid injection alone
Number of subjects: 115
Study: 11034244

Group type: EXPERIMENTAL
Intervention: Total gastrectomy with pancreas tail resection (Group A)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Total gastrectomy without pancreas tail resection (Group B)
Number of subjects: 110
Study: 8826725

Group type: EXPERIMENTAL
Intervention: Picolax
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Picolax following a 3 day low‐residue diet
Number of subjects: 150

Group type: COMPARATOR
Intervention: Kleen‐Prep
Number of subjects: 150
Study: 7829015

Group type: EXPERIMENTAL
Intervention: Cyclical antibiotics (ampicillin, metronidazole, ciprofloxacin) and ursodeoxycholic acid
Number of subjects: 70

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Cyclical antibiotics and ursodeoxycholic acid
Number of subjects: 70
Study: 3220854

Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM) devices
Number of subjects: 10

Group type: COMPARATOR
Intervention: Supervised OT/PT (Control)
Number of subjects: 10
Study: 29502508

Group type: EXPERIMENTAL
Intervention: Acquaintance rape scenario
Number of subjects: 348

Group type: COMPARATOR
Intervention: Stranger rape scenario
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Victim race (Black)
Number of subjects: 348

Group type: COMPARATOR
Intervention: Victim race (White)
Number of subjects: 348
Study: 29904968

Group type: EXPERIMENTAL
Intervention: Cantharidin only
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Cantharidin with occlusion
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo with occlusion
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo only
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Combined cantharidin arms
Number of subjects: 94
Study: 29141460

Group type: EXPERIMENTAL
Intervention: Metformin up-titration (1,500-2,250 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (maintaining low-dose metformin)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Metformin up-titration
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study: 26515419

Group type: EXPERIMENTAL
Intervention: Extended-release niacin (ERN; 1-2 g/d)
Number of subjects: 11
Study: 23207512

Group type: EXPERIMENTAL
Intervention: Infiltrant applied for 1 min
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Infiltrant applied for 3 min
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Infiltrant applied for 5 min
Number of subjects: 34
Study: 20184222

Group type: EXPERIMENTAL
Intervention: Fluoxetine (reference formulation)
Number of subjects: 144
Study: 18383987

Group type: EXPERIMENTAL
Intervention: Intervention group (diet with > 30 g of fiber and < 16 g of saturated fat, exercise 5-6 days/week, strength training 3 days/week, stress management 10-20 minutes daily)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 16723101

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (IMN) 40 mg with dinoprostone 3 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo with dinoprostone 3 mg
Number of subjects: 120
Study: 12590007

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (50 microg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10921762

Group type: EXPERIMENTAL
Intervention: Salbutamol via Diskus (cumulative doses of 200, 400, 800, 1600, and 3200 microg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Salbutamol via Turbuhaler (cumulative doses of 200, 400, 800, 1600, and 3200 microg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 8833682

Group type: EXPERIMENTAL
Intervention: Antidepressant-treated group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Referent group without antidepressant treatment
Number of subjects: 0
Study: 1452374

Group type: COMPARATOR
Intervention: Diltiazem (30 mg three times a day)
Number of subjects: 15
Study: 6483162

Group type: EXPERIMENTAL
Intervention: Doxefazepam 10 mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Doxefazepam 20 mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Doxefazepam 40 mg
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Doxefazepam 10 mg (2-week administration)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Doxefazepam 10 mg (self-administered at home)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 30496845

Group type: EXPERIMENTAL
Intervention: PRP, calcium sulfate, and autologous bone graft
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no PRP, calcium sulfate, or autologous bone graft)
Number of subjects: 20
Study: 30336856

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 82
Study: 27281305

Group type: EXPERIMENTAL
Intervention: Thin 100-kcal shake
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Thick 100-kcal shake
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Thin 500-kcal shake
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Thick 500-kcal shake
Number of subjects: 15
Study: 25213640

Group type: EXPERIMENTAL
Intervention: Pain induced by injection of hypertonic saline into vastus medialis (VM)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Pain induced by injection of hypertonic saline into rectus femoris (RF)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Voluntary reduction of EMG amplitude of RF
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Voluntary reduction of EMG amplitude of VM
Number of subjects: 33
Study: 21874370

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 35

Group type: COMPARATOR
Intervention: ABPR-PAP
Number of subjects: 35
Study: 19536166

Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17364675

Group type: EXPERIMENTAL
Intervention: Medical therapy
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: 5-point decrement in percent predicted FEV1
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: 5-point worsening in SOBQ
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Full model incorporating spirometry, PaO2, dyspnea, prior exacerbations and co-morbidity
Number of subjects: 610
Study: 15734870

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12169127

Group type: EXPERIMENTAL
Intervention: Aminoglycoside and steroid preparation
Number of subjects: 39

Group type: COMPARATOR
Intervention: Steroid preparation without aminoglycoside
Number of subjects: 39
Study: 10451909

Group type: EXPERIMENTAL
Intervention: Intranasal GHRH (300 micrograms)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 8963361

Group type: EXPERIMENTAL
Intervention: Low fat/high fiber diet (25.5 energy‐% fat, 58.5 energy‐% carbohydrate, 3.9 g dietary fiber/MJ)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 48
Study: 1978471

Group type: EXPERIMENTAL
Intervention: Remoxipride twice daily
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Remoxipride three times daily
Number of subjects: 160

Group type: COMPARATOR
Intervention: Haloperidol three times daily
Number of subjects: 160
Study: 111119

Group type: EXPERIMENTAL
Intervention: Cefoxitin, 2 g, intramuscularly
Number of subjects: 107

Group type: COMPARATOR
Intervention: Procaine penicillin G, 4.8 million U, intramuscularly
Number of subjects: 107
Study: 31338640

Group type: EXPERIMENTAL
Intervention: Topical lotion CG428, applied twice per day for 6 months
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo, applied twice per day for 6 months
Number of subjects: 35
Study: 30641749

Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 500

Group type: COMPARATOR
Intervention: Females
Number of subjects: 500
Study: 27362697

Group type: EXPERIMENTAL
Intervention: 12-week high intensity interval plus resistance training (HITR, n = 12)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 12-week high intensity continuous aerobic training plus resistance training (HCTR, n = 11)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sedentary control group (SED, n = 11)
Number of subjects: 34
Study: 25887506

Group type: EXPERIMENTAL
Intervention: Linguistically adapted, evidence-based, health-promoting intervention with a person-centred approach, comprising four group meetings and one follow-up home visit by a multi-professional team.
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 130
Study: 23690352

Group type: EXPERIMENTAL
Intervention: Computer Assisted Relaxation Learning (CARL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Informational pamphlet (Control)
Number of subjects: 0
Study: 22080310

Group type: EXPERIMENTAL
Intervention: Feedback condition
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nonfeedback condition
Number of subjects: 20
Study: 19566401

Group type: EXPERIMENTAL
Intervention: Telemonitoring
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 101
Study: 16686574

Group type: EXPERIMENTAL
Intervention: Balance training using a commercially available balance training device (BOSU)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Balance training
Number of subjects: 36
Study: 15232329

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 to 40 mg/d)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Imipramine (75 to 200 mg/d)
Number of subjects: 60
Study: 11762737

Group type: EXPERIMENTAL
Intervention: Comprehensive counseling group (CCG)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Brief counseling group (BCG)
Number of subjects: 38
Study: 9241284

Group type: EXPERIMENTAL
Intervention: 1.5 g of elemental calcium for 6 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 23
Study: 8231904

Group type: EXPERIMENTAL
Intervention: 17 beta‐oestradiol-releasing vaginal ring (53 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo ring
Number of subjects: 26
Study: 3619421

Group type: EXPERIMENTAL
Intervention: 50 mg/kg mezlocillin
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 80 mg/kg mezlocillin
Number of subjects: 8
Study: 29730331

Group type: EXPERIMENTAL
Intervention: One-set training
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Three-sets training
Number of subjects: 26
Study: 27392513

Group type: EXPERIMENTAL
Intervention: Unilateral pedunculopontine area stimulation
Number of subjects: 6
Study: 25078584

Group type: EXPERIMENTAL
Intervention: Calcitonin and Caltrate D
Number of subjects: 91

Group type: COMPARATOR
Intervention: Caltrate D (Control)
Number of subjects: 91
Study: 22095545

Group type: EXPERIMENTAL
Intervention: Fosfomycin/tobramycin for inhalation (FTI) 160/40 mg
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Fosfomycin/tobramycin for inhalation (FTI) 80/20 mg
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 20516220

Group type: EXPERIMENTAL
Intervention: Corrective feedback during recognition memory tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Corrective feedback in a false-memory procedure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Corrective feedback in a categorization task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deep and shallow encoding of categorized study lists
Number of subjects: 0
Study: 18482967

Group type: EXPERIMENTAL
Intervention: Peer-led HIV/AIDS prevention intervention
Number of subjects: 3068

Group type: COMPARATOR
Intervention: Usual teacher-led health education curriculum
Number of subjects: 3068
Study: 17009499

Group type: EXPERIMENTAL
Intervention: Vision-haptics group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vision-only group
Number of subjects: 20